Daiamed Cambridge, MA - 02141

Daiamed is categorized under Wholesale Pharmaceutical Products in Cambridge, MA and active since 2009.

Daiamed was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4461100 by the NAICS.

If you are seeking more information, feel free to contact Frans Stassen, Chief Executive Officer at the company’s single location by writing to 6 Canal Park Apartment 410, Cambridge, Massachusetts MA 02141 or by phoning (617) 494-0888. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Daiamed
Contact Person: Frans Stassen, Chief Executive Officer
Address: 6 Canal Park Apartment 410, Cambridge, Massachusetts 02141
Phone Number: (617) 494-0888
Website Address: daiamed.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 4461100
Share This Business:

Daiamed was started in 2009 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Frans Stassen, Chief Executive Officer for inquiries that concern Daiamed by calling the company number (617) 494-0888, as your correspondence is most welcome. Additionally, the physical location of the single location of Daiamed can be found at the coordinates 42.369722,-71.074876 as well as the street address 6 Canal Park Apartment 410 in Cambridge, Massachusetts 02141.

For its online presence, you may visit Daiamed’s website at daiamed.com and engage with its social media outlets through on Twitter and on Facebook.